Baseline characteristics of the 107 participants
| . | Users of tamoxifen (n=42) . | Users of aromatase inhibitors (n=65) . |
|---|---|---|
| Age, y | 49.5 (8.9) | 65.5 (9.4) |
| Weight, kg | 65.7 (11.0) | 69.8 (13.9) |
| BMI, kg/m2 | 24.7 (4.5) | 26.4 (4.9) |
| Parity | 1.7 (0.9) | 1.7 (1.2) |
| Nonmenopausal status | 31 (73.8%) | 0 (0%) |
| Previous hysterectomy | 1 (2.4%) | 11 (16.9%) |
| Diabetes | 1 (2.4%) | 7 (10.9%) |
| Hypertension | 2 (4.8%) | 26 (40%) |
| Dyslipidemia | 4 (9.5%) | 19 (29.2%) |
| Current smoking | 8 (19.1%) | 10 (15.4%) |
| Previous coronary heart disease | 0 (0%) | 3 (4.6%) |
| Previous cerebrovascular disease | 0 (0%) | 2 (3.1%) |
| Breast cancer stage | ||
| 0 | 7 (16.7%) | 2 (3.1%) |
| IA | 22 (52.4%) | 33 (50.8%) |
| IB | 2 (4.8%) | 4 (6.2%) |
| IIA | 5 (11.9%) | 16 (24.6%) |
| IIB | 3 (7.1%) | 8 (12.3%) |
| IIIA | 2 (4.5%) | 1 (1.5%) |
| IIIB | 0 (0%) | 1 (1.5%) |
| IIIC | 1 (2.4%) | 0 (0%) |
| Previous cancer treatment | ||
| Breast surgery | 42 (100%) | 64 (98.5%) |
| Time from surgery to inclusion, days | 107 (64) | 104 (73) |
| Breast radiotherapy before inclusion | 33 (78.6%) | 57 (87.7%) |
| . | Users of tamoxifen (n=42) . | Users of aromatase inhibitors (n=65) . |
|---|---|---|
| Age, y | 49.5 (8.9) | 65.5 (9.4) |
| Weight, kg | 65.7 (11.0) | 69.8 (13.9) |
| BMI, kg/m2 | 24.7 (4.5) | 26.4 (4.9) |
| Parity | 1.7 (0.9) | 1.7 (1.2) |
| Nonmenopausal status | 31 (73.8%) | 0 (0%) |
| Previous hysterectomy | 1 (2.4%) | 11 (16.9%) |
| Diabetes | 1 (2.4%) | 7 (10.9%) |
| Hypertension | 2 (4.8%) | 26 (40%) |
| Dyslipidemia | 4 (9.5%) | 19 (29.2%) |
| Current smoking | 8 (19.1%) | 10 (15.4%) |
| Previous coronary heart disease | 0 (0%) | 3 (4.6%) |
| Previous cerebrovascular disease | 0 (0%) | 2 (3.1%) |
| Breast cancer stage | ||
| 0 | 7 (16.7%) | 2 (3.1%) |
| IA | 22 (52.4%) | 33 (50.8%) |
| IB | 2 (4.8%) | 4 (6.2%) |
| IIA | 5 (11.9%) | 16 (24.6%) |
| IIB | 3 (7.1%) | 8 (12.3%) |
| IIIA | 2 (4.5%) | 1 (1.5%) |
| IIIB | 0 (0%) | 1 (1.5%) |
| IIIC | 1 (2.4%) | 0 (0%) |
| Previous cancer treatment | ||
| Breast surgery | 42 (100%) | 64 (98.5%) |
| Time from surgery to inclusion, days | 107 (64) | 104 (73) |
| Breast radiotherapy before inclusion | 33 (78.6%) | 57 (87.7%) |
Numbers are mean (standard deviation) or n (%).